Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells

Details for Australian Patent Application No. 2005265027 (hide)

Owner The Government of The United States of America as represented by the Secretary of Health and Human Services

Inventors Annereau, Jean-Phillipe; Weinstein, John; Lababidi, Samir; Szakacs, Gergely; Gottesman, Michael M.

Agent Griffith Hack

Pub. Number AU-A-2005265027

PCT Pub. Number WO2006/009765

Priority 60/602,640 19.08.04 US; 60/580,397 18.06.04 US

Filing date 16 June 2005

Wipo publication date 26 January 2006

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/009765 Priority application(s): WO2006/009765

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265030-Efficient evaluation of queries using translation

2005265025-One trip well drilling to total depth